Riot nominates three independent directors to Bitfarms board in latest takeover salvo
Quick Take Riot Platforms is calling for a special meeting to reconstitute Bitfarms’ Board. Shareholders will vote on removing and replacing Chairman Nicolas Bonta and director Andrés Finkielsztain as well as to fill the vacancy left by co-founder Emiliano Grodzki Riot withdraws $2.30/share offer, pushing for board changes and fresh perspectives.
As expected, Riot Platforms has formally requisitioned a special meeting of Bitfarms shareholders to reconstitute the Bitfarms Board of Directors.
It's the latest step in Riot's attempted takeover of its bitcoin mining peer. Riot Platforms attempted to acquire Bitfarms in April for roughly $950 million. Since that deal was thwarted, Riot has steadily been buying up stock in Bitfarms to become its largest shareholder. Riot owns about 60 million shares, or 14.9%, of the Bitfarms.
Riot is ready to engage with a reconstituted Bitfarms board around a potential acquisition of Bitfarms but is withdrawing its previous offer to acquire the company for $2.30 per share "given the current board’s lack of meaningful engagement."
"It is clear that directors with fresh perspectives are needed to address the issues in the Bitfarms boardroom. Riot is proposing three highly qualified individuals, each of whom is completely independent of Riot and Bitfarms," Riot said in a press release. "Together, they will bring much needed corporate governance oversight, transaction experience and business expertise to the Bitfarms Board."
Bitfarms has 21 days to schedule the meeting.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Ripple XRP Is No Longer Just A Payments – Here’s 6 Reasons Why
Hacker moves $182K in ETH to Tornado Cash after Voltage exploit

Florida backs out of the Bitcoin game, no reserve
Corporate Crypto Eye $330B—Analysts Say Qubetics, Ethereum, and Injective Are Top Cryptos to Buy This Month
With $330B in corporate crypto demand forecasted, Qubetics, Ethereum, and Injective are standing out. Learn why analysts see Qubetics' $16.7M presale as a top crypto presale and how its cross-border utility redefines real-world blockchain adoption.Cross-Border Simplicity: How Qubetics Is Quietly Disrupting Global TransactionsEthereum Approaches Spectra Upgrade Amid Signs of Imminent VolatilityInjective Gathers Steam with Technical Surge and Bullish OutlookConclusion—And These Are the Top Cryptos to Buy Thi

Trending news
MoreCrypto prices
More








